Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1967 1
1968 1
1974 1
1975 6
1979 2
1980 2
1981 3
1982 9
1983 6
1984 9
1985 7
1986 10
1987 6
1988 9
1989 10
1990 12
1991 7
1992 11
1993 9
1994 19
1995 15
1996 14
1997 24
1998 23
1999 25
2000 32
2001 25
2002 47
2003 85
2004 96
2005 115
2006 162
2007 195
2008 214
2009 269
2010 318
2011 408
2012 469
2013 524
2014 647
2015 693
2016 750
2017 874
2018 986
2019 1183
2020 1402
2021 1707
2022 1987
2023 2015
2024 2270
2025 2474
2026 55

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,180 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.
Fang W, Wu L, Meng X, Yao Y, Zuo W, Yao W, Xie Y, Zhang Y, Cui J, Zhang Y, Li X, Zhuang W, Fang J, Wang Q, Jiang W, Li K, Bai Y, Luo Y, Ma F, Yu Y, Zheng W, Liu Z, Yang B, Ma R, Fang Y, Yang R, Jiang L, Hu J, Yang J, Diao Y, Jin X, Ge J, Yang Y, Zhang L. Fang W, et al. Among authors: bai y. N Engl J Med. 2025 Oct 19. doi: 10.1056/NEJMoa2512071. Online ahead of print. N Engl J Med. 2025. PMID: 41124220
Bradycardia-Associated Pulmonary Hypertension.
Long Y, Li W, Bai Y, Zhou D, Pan W, Ge J. Long Y, et al. Among authors: bai y. JACC Case Rep. 2025 Nov 5;30(35):105540. doi: 10.1016/j.jaccas.2025.105540. Epub 2025 Sep 29. JACC Case Rep. 2025. PMID: 41020751 Free article.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study.
Qin S, Gu S, Chan SL, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Xu L, Yuan X, Li D, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Du J, Shi W, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: bai y. Lancet Oncol. 2025 Dec;26(12):1598-1611. doi: 10.1016/S1470-2045(25)00543-1. Lancet Oncol. 2025. PMID: 41308676 Clinical Trial.
Safety and effectiveness of lecanemab in Chinese patients with early Alzheimer's disease: Evidence from a multidimensional real-world study.
Kang W, Gao C, Li X, Wang X, Zhong H, Wei Q, Tang Y, Huang P, Shen R, Chen L, Zhang J, Fang R, Wei W, Zhang F, Zhou G, Yuan W, Chen X, Yang Z, Wu Y, Xu W, Zhu S, Zhang L, He N, Fang W, Zhang M, Zhang Y, Ju H, Bai Y, Liu J. Kang W, et al. Among authors: bai y. Chin Med J (Engl). 2025 Nov 20;138(22):2907-2916. doi: 10.1097/CM9.0000000000003888. Epub 2025 Oct 27. Chin Med J (Engl). 2025. PMID: 41069006 Free PMC article.
OmniPath: integrated knowledgebase for multi-omics analysis.
Türei D, Schaul J, Palacio-Escat N, Bohár B, Bai Y, Ceccarelli F, Çevrim E, Daley M, Darcan M, Dimitrov D, Doğan T, Domingo-Fernández D, Dugourd A, Gábor A, Gul L, Hall BA, Hoyt CT, Ivanova O, Klein M, Lawrence T, Mañanes D, Módos D, Müller-Dott S, Ölbei M, Schmidt C, Şen B, Theis FJ, Ünlü A, Ulusoy E, Valdeolivas A, Korcsmáros T, Saez-Rodriguez J. Türei D, et al. Among authors: bai y. Nucleic Acids Res. 2025 Nov 18:gkaf1126. doi: 10.1093/nar/gkaf1126. Online ahead of print. Nucleic Acids Res. 2025. PMID: 41251164
18,180 results
You have reached the last available page of results. Please see the User Guide for more information.